Showing results (311-320 of 321) with videos related to
Sort By:
Pageof 33
Circulation. Cardiovascular Quality and Outcomes|April 5, 2023
Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease RegistryEric J Hall, Colby R Ayers, Ahmed A Kolkailah, et al.International Journal of Cardiology|November 22, 2016
Longitudinal treatment patterns with ADP receptor inhibitors after myocardial infarction: Insights from the Canadian Observational AntiPlatelet sTudyAkshay Bagai, Tracy Y Wang, Shaun G Goodman, et al.Journal of Cardiac Failure|October 10, 2024
The Use of Cangrelor in Cardiogenic Shock: Insights from the CAMEO RegistryJennifer Rymer, Cayla Pichan, Courtney Page, et al.JACC. Advances|November 15, 2025
Use of Cangrelor for Patients Undergoing Coronary Artery Bypass Grafting: Insights From the CAMEO RegistryJennifer A Rymer, Courtney Page, Brooke Alhanti, et al.Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary InterventionJoshua P Loh, Li-Ling Tan, Huili Zheng, et al.JAMA Network Open|May 3, 2021
Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 PandemicGregory A Roth, Sophia Emmons-Bell, Heather M Alger, et al.Circulation|November 1, 2017
International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting TherapiesDominick J Angiolillo, Fabiana Rollini, Robert F Storey, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO RegistryJennifer Rymer, Brooke Alhanti, Steven Kemp, et al.American Heart Journal|November 15, 2019
Claims-based cardiovascular outcome identification for clinical research: Results from 7 large randomized cardiovascular clinical trialsJ Matthew Brennan, Lisa Wruck, Michael J Pencina, et al.NEJM Evidence|February 6, 2024
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic ValveTracy Y Wang, Lars G Svensson, Jun Wen, et al.Pageof 33